|
 |
||||
 |
|
|
|
||
|
Calydon, Inc. – Realized NASDAQ: CEGE Calydon, Inc., a gene therapy company focused on the development and commercialization of cancer vaccines and gene therapies to treat major, life-threatening diseases, was acquired by Cell Genesys, Inc. in September 2001.
|
|||||
© 2001-06 PERSEUS, L.L.C., Designer: Beebe Communications, Inc. — Site updated |
|||||
